|
시장보고서
상품코드
1890941
천골신경조절 시장 : 제품 유형별, 용도별, 최종사용자별, 환자 연령층별, 기술별, 지역별Sacral Neuromodulation Market, By Product Type, By Application, By End User, By Patient Age Group, By Technology, By Geography |
||||||
천골신경조절 시장은 2025년에 19억 1,000만 달러로 추정되며, 2032년까지 40억 7,000만 달러에 달할 것으로 예측됩니다. 2025-2032년 CAGR 11.4%로 성장할 것으로 전망되고 있습니다.
| 리포트 커버 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2024년 | 2025년 시장 규모 : | 19억 1,000만 달러 |
| 과거 데이터 대상 기간 : | 2020-2024년 | 예측 기간 : | 2025-2032년 |
| 예측 기간인 2025-2032년의 CAGR : | 11.40% | 2032년 예측 : | 40억 7,000만 달러 |
세계 천골 신경조절 시장은 광범위한 신경조절 산업의 전문 분야로, 천골 신경에 대한 표적 전기 자극을 통해 다양한 골반저 장애를 치료하기 위해 설계된 혁신적인 의료기기에 초점을 맞추었습니다. 천골신경조절술(일명 천골신경자극요법, SNS)은 과민성 방광, 요폐, 변실금, 만성골반통 증후군 등의 심각한 증상을 치료하는 저침습적 치료법으로 등장했습니다. 이 첨단 의료기술은 천골신경에 제어된 전기 펄스를 보내 방광, 장, 골반저 기능에 관여하는 신경 경로를 효과적으로 조절하는 소형 장치를 체내에 이식하는 첨단 의료기술입니다.
시장에는 임플란트형 펄스 발생기, 리드선, 외부 자극기, 관련 수술기구 등 다양한 컴포넌트가 포함되어 있습니다. 골반저 장애에 대한 인식이 높아지고, 고령화 인구 증가, 최소침습적 시술에 대한 수용이 확대됨에 따라 천골신경조절 시장은 괄목할 만한 성장세를 보이고 있습니다. 의료 서비스 프로바이더들은 만성 골반 질환과 관련된 장기적인 의료 비용을 절감하고 환자의 삶의 질을 크게 향상시키는 비용 효율적인 치료 옵션으로 SNS를 점점 더 많이 인식하고 있습니다. 시장 확대는 충전식 장치, MRI 지원 시스템, 치료 효과와 환자 편의성을 향상시키는 개선된 프로그래밍 기능 등 지속적인 기술 발전으로 더욱 지원되고 있습니다.
시장 역학
세계 천골 신경조절 시장은 견고한 성장 궤도를 지원하는 여러 강력한 촉진요인에 의해 주도되고 있습니다. 주요 촉진요인은 특히 전 세계 고령화 인구에서 과민성 방광 및 요실금과 같은 질환이 나이가 들어감에 따라 증가하는 경향이 있는 골반저 장애의 유병률 증가에 기인합니다. 기존 수술적 개입을 대체할 수 있는 최소침습적 대안으로서 천골신경조절술의 효과에 대한 의료진과 환자들의 인식이 높아진 것도 시장 확대에 크게 기여하고 있습니다. 충전식 이식형 펄스 발생기, MRI 지원 장치, 고급 프로그래밍 시스템 등의 기술 발전은 치료 결과를 개선하고 대상 환자층을 확대하고 있습니다.
그러나 시장에는 성장 잠재력을 제한할 수 있는 뚜렷한 제약이 존재합니다. 특히 비용에 민감한 의료 시스템이나 상환 범위가 제한적인 개발도상국에서는 장비의 높은 비용과 관련 수술 비용이 도입의 큰 장벽이 될 수 있습니다. 환자 선택 기준의 복잡성과 의료진에 대한 전문적 훈련의 필요성은 특정 지역에서 시장 침투를 제한할 수 있습니다. 또한 감염 위험과 기기 고장과 같은 장치 삽입에 따른 잠재적 합병증은 환자와 의사 모두 이 치료법을 채택하는 것을 주저하게 만들 수 있습니다. 이러한 과제에도 불구하고 만성골반통, 간질성 방광염, 신경인성 방광장애 등 기존 적응증을 넘어선 천골신경조절기술의 적용 확대로 인해 큰 기회가 생기고 있습니다. 신흥 시장의 의료 인프라 확충, 의료비 지출 증가, 상환 정책의 개선이 결합되어 지역적 확장을 목표로 하는 시장 기업에게 큰 성장 기회를 제공합니다.
본 조사의 주요 특징
- 이 보고서는 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 시장 규모(10억 달러)와 예측 기간(2025-2032년)의 연평균 성장률(CAGR)을 나타내는 세계 천골 신경조절 시장에 대한 상세한 분석 정보를 제공합니다.
- 또한 각 부문의 잠재적 매출기회를 확인하고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 설명합니다.
- 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 또는 승인, 시장 동향, 지역별 전망, 주요 업체들의 경쟁 전략에 대한 중요한 정보를 제공합니다.
- 이 보고서는 기업 개요, 제품 포트폴리오, 주요 특징, 재무 성과, 전략 등 다양한 매개 변수를 기반으로 세계 천골 신경조절 시장의 주요 기업 개요을 제공합니다.
- 이 보고서는 마케팅 담당자와 기업 경영진이 향후 제품 출시, 모델 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있도록 돕습니다.
- 이 세계 천골 신경조절 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 천골 신경조절 시장 분석에 사용된 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있습니다.
목차
제1장 조사 목적과 전제조건
- 조사 목적
- 전제조건
- 약어
제2장 시장 범위
- 리포트 개요
- 시장 정의와 범위
- 개요
제3장 시장 역학, 규제 및 동향 분석
- 시장 역학
- 촉진요인
- 억제요인
- 기회
- 영향 분석
- 주요 발전
- 규제 환경
- 제품 발매·승인
- PEST 분석
- Porter의 산업 분석
- 합병·인수의 동향
- 업계 동향
제4장 세계의 천골신경조절 시장 : 제품 유형별, 2020-2032년
- 이식형 펄스 발생기(IPG)
- 리드 전극
- 외부/비이식형 펄스 발생기(EPG)
- 부속품 및 시스템 컴포넌트
제5장 세계의 천골신경조절 시장 : 용도별, 2020-2032년
- 요실금(복압성, 임박성, 혼합성)
- 과민성 방광(OAB)
- 변실금
- 요폐
- 만성 골반통 및 관련 골반저 장애
- 기타(예 : 위장 운동 기능 장애, 소아과 영역 등)
제6장 세계의 천골신경조절 시장 : 최종사용자별, 2020-2032년
- 병원 및 대규모 의료 센터
- 외래 수술 센터(ASC)
- 전문 클리닉(비뇨기과/소화기과/골반 건강)
- 연구기관 및 학술기관
제7장 세계의 천골신경조절 시장 : 환자 연령층별, 2020-2032년
- 소아
- 성인
- 고령자
제8장 세계의 천골신경조절 시장 : 기술별, 2020-2032년
- 충전식 시스템
- 비충전식 시스템
- 유선/리드 시스템과 무선/리드리스 시스템의 비교
- 시험용 시스템(일시적 리드) 대 영구 시스템
제9장 세계의 천골신경조절 시장 : 지역별, 2020-2032년
- 북미
- 미국
- 캐나다
- 라틴아메리카
- 브라질
- 아르헨티나
- 멕시코
- 기타 라틴아메리카 국가
- 유럽
- 독일
- 영국
- 스페인
- 프랑스
- 이탈리아
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- 호주
- 한국
- ASEAN
- 기타 아시아태평양
- 중동
- GCC 국가
- 이스라엘
- 기타 중동 국가
- 아프리카
- 남아프리카
- 북아프리카
- 중앙아프리카
제10장 경쟁 구도
- Medtronic plc
- Boston Scientific Corporation
- Abbott Laboratories
- Axonics Inc
- Nevro Corp
- LivaNova PLC
- NeuroPace Inc
- Synapse Biomedical Inc
- Beijing PINS Medical Co., Ltd
- Saluda Medical Pty Ltd
- Nuvectra Corp
- Johnson and Johnson
- Valencia Technologies
- EBT Medical
- Inspire Medical Systems
제11장 애널리스트의 권장사항
- 기회
- 애널리스트의 견해
- Coherent Opportunity Map
제12장 참고 문헌 및 조사 방법
- 참고 문헌
- 조사 방법
- 출판사 소개
Sacral Neuromodulation Market is estimated to be valued at USD 1.91 Bn in 2025 and is expected to reach USD 4.07 Bn by 2032, growing at a compound annual growth rate (CAGR) of 11.4% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 1.91 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 11.40% | 2032 Value Projection: | USD 4.07 Bn |
The global sacral neuromodulation market represents a specialized segment within the broader neuromodulation industry, focusing on innovative medical devices designed to treat various pelvic floor disorders through targeted electrical stimulation of sacral nerves. Sacral neuromodulation, also known as sacral nerve stimulation (SNS), has emerged as a minimally invasive therapeutic approach that addresses debilitating conditions including overactive bladder, urinary retention, fecal incontinence, and chronic pelvic pain syndromes. This advanced medical technology involves the implantation of small devices that deliver controlled electrical pulses to the sacral nerves, effectively modulating neural pathways responsible for bladder, bowel, and pelvic floor function.
The market encompasses various components including implantable pulse generators, leads, external stimulators, and associated surgical instruments. With growing awareness of pelvic floor disorders, aging demographics, and increasing acceptance of minimally invasive procedures, the sacral neuromodulation market has witnessed substantial growth trajectory. Healthcare providers increasingly recognize SNS as a cost-effective treatment option that significantly improves patients' quality of life while reducing long-term healthcare costs associated with chronic pelvic conditions. The market's expansion is further supported by ongoing technological advancements, including rechargeable devices, MRI-compatible systems, and improved programming capabilities that enhance treatment efficacy and patient comfort.
Market Dynamics
The global sacral neuromodulation market is propelled by several compelling drivers that collectively fuel its robust growth trajectory. The primary driver stems from the increasing prevalence of pelvic floor disorders, particularly among aging populations worldwide, where conditions like overactive bladder and fecal incontinence become more common with advancing age. Rising awareness among healthcare professionals and patients regarding the efficacy of sacral neuromodulation as a minimally invasive alternative to traditional surgical interventions significantly contributes to market expansion. Technological advancements, including the development of rechargeable implantable pulse generators, MRI-compatible devices, and sophisticated programming systems, enhance treatment outcomes and broaden the addressable patient population.
However, the market faces notable restraints that could potentially limit its growth potential. High device costs and associated surgical expenses create significant barriers to adoption, particularly in cost-sensitive healthcare systems and developing regions with limited reimbursement coverage. The complexity of patient selection criteria and the requirement for specialized training among healthcare providers can restrict market penetration in certain geographical areas. Additionally, potential complications associated with device implantation, including infection risks and device malfunction, may deter both patients and physicians from adopting this therapy. Despite these challenges, substantial opportunities emerge from expanding applications of sacral neuromodulation technology beyond traditional indications, including chronic pelvic pain, interstitial cystitis, and neurogenic bladder conditions. Growing healthcare infrastructure in emerging markets, coupled with increasing healthcare expenditure and improving reimbursement policies, presents significant growth opportunities for market players seeking geographical expansion.
Key Features of the Study
- This report provides in-depth analysis of the global sacral neuromodulation market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global sacral neuromodulation market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Axonics Inc, Nevro Corp, LivaNova PLC, NeuroPace Inc, Synapse Biomedical Inc, Beijing PINS Medical Co., Ltd, Saluda Medical Pty Ltd, Nuvectra Corp, Johnson and Johnson, Valencia Technologies, EBT Medical, and Inspire Medical Systems.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global sacral neuromodulation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global sacral neuromodulation market
Market Segmentation
- Product Type Insights (Revenue, USD Bn, 2020 - 2032)
- Implantable Pulse Generators (IPGs)
- Lead Electrodes
- External/Non Implantable Pulse Generators (EPGs)
- Accessories and System Components
- Application Insights (Revenue, USD Bn, 2020 - 2032)
- Urinary Incontinence (stress, urge, mixed)
- Overactive Bladder (OAB)
- Fecal Incontinence
- Urinary Retention
- Chronic Pelvic Pain and Related Pelvic Floor Disorders
- Others (e.g., gastrointestinal motility disorders, pediatric indications)
- End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals and Large Medical Centres
- Ambulatory Surgical Centers (ASCs)
- Specialty Clinics (Urology/Gastroenterology/Pelvic Health)
- Research and Academic Institutes
- Patient Age Group Insights (Revenue, USD Bn, 2020 - 2032)
- Pediatric
- Adult
- Geriatric
- Technology Insights (Revenue, USD Bn, 2020 - 2032)
- Rechargeable Systems
- Non Rechargeable Systems
- Wired/Lead Systems vs Wireless/Leadless Systems
- Trial Systems (temporary leads) vs Permanent Systems
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Medtronic plc
- Boston Scientific Corporation
- Abbott Laboratories
- Axonics Inc
- Nevro Corp
- LivaNova PLC
- NeuroPace Inc
- Synapse Biomedical Inc
- Beijing PINS Medical Co., Ltd
- Saluda Medical Pty Ltd
- Nuvectra Corp
- Johnson and Johnson
- Valencia Technologies
- EBT Medical
- Inspire Medical Systems
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Sacral Neuromodulation Market, By Product Type
- Global Sacral Neuromodulation Market, By Application
- Global Sacral Neuromodulation Market, By End User
- Global Sacral Neuromodulation Market, By Patient Age Group
- Global Sacral Neuromodulation Market, By Technology
- Global Sacral Neuromodulation Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Sacral Neuromodulation Market, By Product Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Implantable Pulse Generators (IPGs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Lead Electrodes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- External/Non Implantable Pulse Generators (EPGs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Accessories and System Components
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Sacral Neuromodulation Market, By Application, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Urinary Incontinence (stress, urge, mixed)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Overactive Bladder (OAB)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Fecal Incontinence
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Urinary Retention
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Chronic Pelvic Pain and Related Pelvic Floor Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others (e.g., gastrointestinal motility disorders, pediatric indications)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Sacral Neuromodulation Market, By End User, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospitals and Large Medical Centres
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Ambulatory Surgical Centers (ASCs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Specialty Clinics (Urology/Gastroenterology/Pelvic Health)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Research and Academic Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Sacral Neuromodulation Market, By Patient Age Group, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Sacral Neuromodulation Market, By Technology, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Rechargeable Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Non Rechargeable Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Wired/Lead Systems vs Wireless/Leadless Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Trial Systems (temporary leads) vs Permanent Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Sacral Neuromodulation Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- Medtronic plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Boston Scientific Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Axonics Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Nevro Corp
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- LivaNova PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- NeuroPace Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Synapse Biomedical Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Beijing PINS Medical Co., Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Saluda Medical Pty Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Nuvectra Corp
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson and Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Valencia Technologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- EBT Medical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Inspire Medical Systems
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
